Skip to main content
. 2017 Jul 11;11(1):123–129. doi: 10.1093/ckj/sfx054

Table 1.

Demographics and clinical characteristics for patients surveyed at one of the time points

Parameters 1–30 days after incident HD 121–150 days incident HD P-value
Number of patients (total = 270) 178 92 NA
Average age, years (±SD) 64.1 (±16.3) 63.7 (±13.6) 0.829
Female (%) 39.9 41.3 0.822
Diabetes (%) 67.1 67.9 0.909
Hypothyroidism (%) 8.4 8.7 0.940
Race, White (%) 74.2 63.0 0.058
Ethnicity, not Hispanic (%) 80.9 95.7 0.001
BMI, kg/m2 (±SD) 29.6 (±8.1) 30.2 (±7.8) 0.608
Catheter access (%) 52.7 15.5 <0.0001
Albumin, g/dL (±SD) 3.5 (±0.5) 3.8 (±0.5) 0.001
Log of creatinine (±SD) 1.6 (±0.4) 1.9 (±0.4) <0.0001
OLC (±SD) 1.4 (±0.3) 1.6 (±0.3) <0.0001
PreSBP, mmHg (±SD) 145.0 (±20.3) 150.3 (±20.0) 0.058
Percent IDWG (±SD) 2.1 (±1.1) 2.9 (±1.0) <0.0001
Average PHQ2 score 1.2 (±2.0) 1.2 (±1.6) 0.705
Patients with positive PHQ2 scores (≥3) (%) 20.2 18.5 0.731

Summary of incident HD patient demographics, diabetes comorbidity, dialysis access characteristics and PHQ2 scores in patients that responded to the depressive affect screening at either 1–30 days or 121–150 days after initiating dialysis.